𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus quasispecies in chronically infected children subjected to interferon–ribavirin therapy

✍ Scribed by Magdalena Figlerowicz; Paulina Jackowiak; Piotr Formanowicz; Paweł Kędziora; Magdalena Alejska; Nelli Malinowska; Jacek Błażewicz; Marek Figlerowicz

Publisher
Springer Vienna
Year
2010
Tongue
English
Weight
682 KB
Volume
155
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon and ribavirin thera
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-Sauné; J.P. Vinel; L. A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

Genetic variability of hepatitis C virus
Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon–ribavirin therapy
✍ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w

Hepatitis C Virus p7 membrane protein qu
Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine
✍ S. Castelain; D. Bonte; F. Penin; C. François; D. Capron; S. Dedeurwaerder; P. Z 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

## Abstract A clinical study was carried out to compare the response rate of two groups of non‐responder (NR) hepatitis C virus (HCV) genotype 1 chronically infected patients treated with interferon and ribavirin, with or without amantadine. The viral load decreased more markedly in the group treat

Changes in antibody titers to hepatitis
Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection
✍ MD Akihiko Urushihara; Takeshi Sodeyama; Akihiro Matsumoto; Eiji Tanaka 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 804 KB

## Abstract The use of quantitative assays for hepatitis C virus specific antibodies (anti‐HCV) as a prognostic marker was evaluated in 31 patients with chronic hepatitis C treated with interferon (IFN). Changes in titers of serum HCV‐RNA and anti‐HCV antibodies; anti‐C11 (anti‐core), anti‐C100 (an

Hepatitis C viral quasispecies and liver
Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection
✍ J Hayashi; Y Kishihara; K Yamaji; N Furusyo; T Yamamoto; Y Pae; Y Etoh; H Ikemat 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

To clarify the virological differences in patients with chronic hepatitis C virus (HCV) infection with and without liver damage, we assessed HCV markers in 306 patients from a rural area of Japan. Genotypes of HCV RNA were determined by polymerase chain reaction, and levels of RNA were determined by